ASX - By Stock
|
CXO |
Re:
Give Reason to hold or invest in CXO
|
|
MJ07
|
212 |
74K |
10 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
212
|
74K
|
10
|
|
ASX - By Stock
|
CXO |
Re:
Give Reason to hold or invest in CXO
|
|
MJ07
|
212 |
74K |
5 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
212
|
74K
|
5
|
|
Charts
|
MSB |
Re:
chart
|
|
MJ07
|
68 |
34K |
0 |
06/06/24 |
06/06/24 |
Charts
|
68
|
34K
|
0
|
|
Charts
|
MSB |
Re:
chart
|
|
MJ07
|
68 |
34K |
0 |
06/06/24 |
06/06/24 |
Charts
|
68
|
34K
|
0
|
|
Charts
|
MSB |
Re:
chart
|
|
MJ07
|
68 |
34K |
0 |
06/06/24 |
06/06/24 |
Charts
|
68
|
34K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
MJ07
|
5.3K |
2.6M |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
MJ07
|
10K |
4.7M |
2 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
10K
|
4.7M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
MJ07
|
10K |
4.7M |
5 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
10K
|
4.7M
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes TLX250-CDx (Zircaix) BLA Submission
|
|
MJ07
|
32 |
10K |
7 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
32
|
10K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
MJ07
|
5.3K |
2.6M |
7 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
MJ07
|
5.3K |
2.6M |
5 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
MJ07
|
231 |
119K |
2 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
231
|
119K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
MJ07
|
882 |
340K |
6 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
882
|
340K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: AGM Chair Address & CEO Presentation
|
|
MJ07
|
76 |
33K |
0 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
76
|
33K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
MJ07
|
882 |
340K |
5 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
882
|
340K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
MJ07
|
882 |
340K |
1 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
882
|
340K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
MJ07
|
882 |
340K |
6 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
882
|
340K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
MJ07
|
882 |
340K |
2 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
882
|
340K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
MJ07
|
882 |
340K |
4 |
28/05/24 |
28/05/24 |
ASX - By Stock
|
882
|
340K
|
4
|
|
ASX - By Stock
|
SBM |
Re:
Ann: Simberi Q4 Oxide Operations Update and FY24 Guidance Change
|
|
MJ07
|
65 |
20K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
65
|
20K
|
1
|
|
ASX - By Stock
|
SBM |
Re:
Ann: Simberi Q4 Oxide Operations Update and FY24 Guidance Change
|
|
MJ07
|
65 |
20K |
2 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
65
|
20K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
MJ07
|
231 |
119K |
2 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
231
|
119K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
MJ07
|
231 |
119K |
1 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
231
|
119K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
MJ07
|
231 |
119K |
0 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
231
|
119K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
MJ07
|
231 |
119K |
4 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
231
|
119K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes Proof-of-Concept Study for Alpha Therapy
|
|
MJ07
|
40 |
11K |
0 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
40
|
11K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
MJ07
|
5.3K |
2.6M |
12 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
MJ07
|
5.3K |
2.6M |
12 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
12
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Completes Proof-of-Concept Study for Alpha Therapy
|
|
MJ07
|
40 |
11K |
2 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
40
|
11K
|
2
|
|
ASX - By Stock
|
CXO |
Re:
Give Reason to hold or invest in CXO
|
|
MJ07
|
212 |
74K |
5 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
212
|
74K
|
5
|
|
ASX - By Stock
|
CXO |
Re:
Give Reason to hold or invest in CXO
|
|
MJ07
|
212 |
74K |
3 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
212
|
74K
|
3
|
|
ASX - By Stock
|
CXO |
Re:
Give Reason to hold or invest in CXO
|
|
MJ07
|
212 |
74K |
1 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
212
|
74K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
MJ07
|
5.3K |
2.6M |
2 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
5.3K
|
2.6M
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
MJ07
|
10K |
4.7M |
15 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
10K
|
4.7M
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
MJ07
|
10K |
4.7M |
11 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
10K
|
4.7M
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
MJ07
|
10K |
4.7M |
7 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
10K
|
4.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Eric Rose
|
|
MJ07
|
30 |
12K |
1 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
30
|
12K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Eric Rose
|
|
MJ07
|
30 |
12K |
12 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
30
|
12K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
MJ07
|
605 |
272K |
1 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
605
|
272K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
MJ07
|
605 |
272K |
7 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
605
|
272K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
MJ07
|
605 |
272K |
2 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
605
|
272K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Eric Rose
|
|
MJ07
|
45 |
20K |
6 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
45
|
20K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 3Y for Eric Rose
|
|
MJ07
|
45 |
20K |
5 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
45
|
20K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
MJ07
|
558 |
183K |
2 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
558
|
183K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
MJ07
|
10K |
4.7M |
12 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
10K
|
4.7M
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q1 2024 quarterly activity and cash flow report
|
|
MJ07
|
15 |
7.2K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
15
|
7.2K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Q1 2024 quarterly activity and cash flow report
|
|
MJ07
|
15 |
7.2K |
25 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
15
|
7.2K
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trofinetide accepted for Priority Review by Health Canada
|
|
MJ07
|
8 |
4.7K |
6 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
8
|
4.7K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
MJ07
|
194 |
77K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
194
|
77K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
MJ07
|
10K |
4.7M |
2 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
10K
|
4.7M
|
2
|
|